Puretech Health News

Express News | PureTech Health Announces Merger Agreement Between Akili and Virtual Therapeutics to Form Leading Digital Health Company

BenzingaMay 29 08:11 ET

PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company

Akili to operate as wholly owned subsidiary of Virtual Therapeutics PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted today

BusinesswireMay 29 08:09 ET

PureTech to Present at the Jefferies Global Healthcare Conference

Business WireMay 23 07:00 ET

PureTech Health Sets $100 Mln Capital Return To Shareholders

RTTNewsMay 20 02:34 ET

PureTech Health Announces Launch of $100M Tender Offer At Premium Price of 250 Pence Per Share

The Company is offering to purchase up to 33,500,000 Ordinary Shares (including Ordinary Shares represented by ADSs) representing approximately 12 percent of the Company's issued ordinary share capita

BenzingaMay 20 02:33 ET

PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender Offer").

BusinesswireMay 20 02:00 ET

PureTech Founded Entity Seaport Therapeutics Presents Data From Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, a biopharmaceutical company that is charting a proven path in neuropsychiatry, today announced two poster presentations detailing the results from multiple clinical trials of SPT-300 at the Society of Biological Psychiatry Annual Meeting in Austin, TX. SPT-300 has been shown to retain the activity and potency of natural allopregnanolone in an oral form and has the potential to capture the breadth of the naturally occurring neurosteroid, which is believed to have significant therapeutic potential in a range of mood and anxiety disorders, including anxious depression.

BusinesswireMay 9 07:05 ET

PureTech Health: Share Capital and Pipeline Update

TipRanksMay 1 03:11 ET

PureTech Health Plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 30 08:37 ET

Earnings Call Summary | Puretech Health(PRTC.US) Q4 2023 Earnings Conference

The following is a summary of the PureTech Health Plc (PRTC) Q4 2023 Earnings Call Transcript:Financial Performance:PureTech Health ended 2023 with cash, cash equivalents and short-term investments of

moomoo AIApr 26 12:41 ET · Conference Call

PureTech Health Plc (PRTC) Q4 2023 Earnings Call Transcript

PureTech Health plc (PRTC) Q4 2023 Earnings Call Transcript

Earnings Call TranscriptsApr 25 23:56 ET

Express News | PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY

BenzingaApr 25 05:38 ET

Press Release: PureTech Announces Annual Results -44-

On May 9, 2022, the Group announced the commencement of a $50,000 share repurchase program (the "Program") of its ordinary shares of one pence each. In February 2024, the Group completed the Program a

Dow JonesApr 25 05:35 ET

PureTech Announces Annual Results for Year Ended December 31, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024.

BusinesswireApr 25 05:22 ET

PureTech Health Reports Strong 2023 Financial Position

TipRanksApr 25 03:10 ET

Earnings Flash (PRTC.L) PURETECH HEALTH Reports FY23 Revenue $3.3M

02:13 AM EDT, 04/25/2024 (MT Newswires) -- Earnings Flash (PRTC.L) PURETECH HEALTH Reports FY23 Revenue $3.3M

MT NewswiresApr 25 02:13 ET

Earnings Flash (PRTC.L) PURETECH HEALTH Posts FY24 Loss $-0.24

02:13 AM EDT, 04/25/2024 (MT Newswires) -- Earnings Flash (PRTC.L) PURETECH HEALTH Posts FY24 Loss $-0.24

MT NewswiresApr 25 02:13 ET

PureTech Health Schedules Annual Financial Results Release

TipRanksApr 18 02:51 ET

Express News | PureTech Completes Enrollment In Phase 2b ELEVATE IPF Trial Of LYT-100 (Deupirfenidone) In Idiopathic Pulmonary Fibrosis; Topline Results Expected In Q4 Of 2024

Moomoo 24/7Apr 16 07:04 ET

Express News | PureTech's LYT-200 Secures Receives FDA Fast Track Designation For Head And Neck Cancers

Moomoo 24/7Apr 11 07:18 ET